San Francisco-based veterinary drug developer Jaguar Animal Health Inc., backed by China-focused life sciences private equity investor BVCF, is planning an IPO on the NASDAQ to raise as much as US$54 million, according to a regulatory filing. The company is planing to sell five million shares at an indicative price range of of US$7 to […]

Visit ChinaMoneyNetwork.com for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.